Oxford Expression Technologies baculovirus protein expression.
Oxford Expression Technologies baculovirus protein expression.
FlashBAC™ is a one step high throughput baculovirus based protein expression platform that enables fast and simultaneous production of multiple recombinant viruses suitable for small and large protein expression systems allowing scientists to produce proteins faster, more easily and cost-effectively.
Oxford Expression Technologies Ltd. (OET) has emerged from a collaboration between Oxford Brookes University and the Natural Environment Research Council. It provides products, services and consultancy to the global pharmaceutical and biotechnology industries. The core business of OET is baculovirus protein expression.
OET's success has been built around the company’s core technology, flashBACTM . flashBACTM is a one step high throughput baculovirus based protein expression platform that enables fast and simultaneous production of multiple recombinant viruses suitable for small and large protein expression systems allowing scientists to produce proteins faster, more easily and cost-effectively.
OET has a high interest in other areas and applications of insect expression systems in order to broaden its portfolio. In particular (OET has strong interests in novel applications such as Virus Like Particle production and the BacMam system.
The portfolio of OET can be divided into Baculovirus products and Insect Cell Culture Products. Within the range of the Baculovirus products OET offers the flashBAC™ baculovirus expression vectors and baculovirus qPCR titration kit, transfection reagents and transfer plasmids. Successful baculovirus protein expression relies on having healthy and robust cell cultures. The OET range of insect cell culture products can help to ensure this. OET provides a variety Spodoptera frugiperda insect cell lines from stock. These cell lines are designed to maximize the production of specific target proteins.
Please contact Sanbio if you would like to learn more about the product portfolio of Oxford Expression Technologies Ltd.